Table 2.
Actual distribution of weight bands in TB patients across different regions of endemicitya
| Range | Weight band (kg) | Distribution (%) |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Africa | Mexico | Peru | China | India | Korea | Taiwan | Thailand | Malaysia | ||
| WR1 | <40.0 | 4 | 10 | 3 | 5 | 19 | 4 | 7 | 9 | 5 |
| WR2 | 40.0–45.0 | 13 | 15 | 7 | 6 | 29 | 8 | 11 | 14 | 9 |
| WR3 | 45.1–55.0 | 41 | 25 | 37 | 37 | 37 | 18 | 29 | 44 | 20 |
| WR4 | 55.1–75.0 | 40 | 40 | 49 | 42 | 14 | 60 | 45 | 31 | 57 |
| WR5 | >75.0 | 3 | 10 | 4 | 10 | 1 | 10 | 8 | 2 | 10 |
a
Data are derived from the REMoxTB trial (Clinical Trials identifier NCT00864383 [http://ClinicalTrials.gov]). This is a randomized placebo-controlled double-blind trial comparing two treatment-shortening regimens with the standard regimen.